Drug reimbursement reduction annulled in France

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.424, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New drug listings for reimbursement in New Zealand

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Reimbursement decision for drotrecogin alfa, drug-eluting stents

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Revised reimbursement drug prices reflect price cuts in Japan

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 256, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision

By Trifirò G.

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 619-625

Springer Publishing Company

Access to resources Recommend Favorite

Using Policy Simulation to Predict Drug Plan Expenditure when Planning Reimbursement Changes

By Dormuth Colin R. Burnett Sean Schneeweiss Sebastian

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1021-1030

Adis International

Access to resources Recommend Favorite